| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8624033 | Endocrinología y Nutrición | 2016 | 9 Pages |
Abstract
Patients treated with GLP-1 RAs caused lower direct healthcare costs for the National Health System than patients treated with insulin. The results may be explained by greater treatment adherence and lower hypoglycemia rates in patients treated with GLP-1 RAs. Additional studies are needed to confirm these possibilities.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Raúl Morano, LucÃa RuÃz,